The impact of coronavirus disease 2019 pandemic on bronchiolitis (lower respiratory tract infection) due to respiratory syncytial virus: A systematic review and meta-analysis
- PMID: 37459026
- DOI: 10.4103/ijph.ijph_1334_22
The impact of coronavirus disease 2019 pandemic on bronchiolitis (lower respiratory tract infection) due to respiratory syncytial virus: A systematic review and meta-analysis
Abstract
The coronavirus disease 2019 (COVID-19) pandemic has changed the epidemiology of respiratory syncytial virus (RSV) infection which accounts for most bronchiolitis and viral pneumonias in infants. This systematic review and meta-analysis aimed to quantitatively assess the effect of the COVID-19 pandemic on RSV-associated bronchiolitis among hospitalized infants. The study protocol was registered in the PROSPERO database (CRD42022314000) and was designed based on Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines updated in May 2020. The meta-analysis component was modified appropriately to synthesize the pooled proportion of infants having RSV-associated bronchiolitis before the COVID-19 pandemic in 2019 and during the pandemic with 95% confidence interval (CI). We identified and screened 189 articles and systematically reviewed 50 full texts. Eight qualified studies from Europe and China, including 109,186 symptomatic cases of bronchiolitis before the pandemic in 2019 and 61,982 cases in 2020-2021 were pooled by random-effects meta-analysis. The quantitative analysis included laboratory-confirmed RSV infection in 7691 infants with bronchiolitis reported before the pandemic in 2019. Meanwhile, during the pandemic, 4964 bronchiolitis cases were associated with RSV infection. The pooled proportion of RSV-associated bronchiolitis cases before the pandemic in 2019 was 16.74% (95% CI 11.73, 22.43%, 95% prediction interval 0.032, 34.16). The pooled proportion of confirmed RSV cases during the pandemic in 2020/2021 was 19.20% (95% CI 12.01, 27.59%, 95% prediction interval 0.046, 42.35). There was an increase in RSV activity after the relaxation of stringent public health measures during the COVID-19 pandemic.
Keywords: Bronchiolitis; coronavirus disease 2019; pandemic; respiratory syncytial virus; severe acute respiratory syndrome coronavirus 2.
Conflict of interest statement
None
Similar articles
-
Clinical Phenotype of Respiratory Syncytial Virus Bronchiolitis before and during the Coronavirus Disease 2019 Pandemic.Am J Perinatol. 2024 Mar;41(4):515-521. doi: 10.1055/s-0042-1759602. Epub 2022 Dec 21. Am J Perinatol. 2024. PMID: 36543242
-
Respiratory syncytial virus: can we still believe that after pandemic bronchiolitis is not a critical issue for public health?Eur J Pediatr. 2023 Dec;182(12):5303-5313. doi: 10.1007/s00431-023-05201-y. Epub 2023 Sep 20. Eur J Pediatr. 2023. PMID: 37728752 Free PMC article.
-
Respiratory syncytial virus bronchiolitis in congenital diaphragmatic hernia: A systematic review of prevalence rates and palivizumab prophylaxis.Pediatr Pulmonol. 2022 Jan;57(1):239-244. doi: 10.1002/ppul.25717. Epub 2021 Oct 12. Pediatr Pulmonol. 2022. PMID: 34617409
-
Systematic review and meta-analysis of respiratory syncytial virus infection epidemiology in Latin America.Rev Med Virol. 2014 Mar;24(2):76-89. doi: 10.1002/rmv.1775. Rev Med Virol. 2014. PMID: 24757727 Review.
-
Impact of COVID‑19 pandemic restrictions and subsequent relaxation on the prevalence of respiratory virus hospitalizations in children.BMC Pediatr. 2024 Feb 2;24(1):91. doi: 10.1186/s12887-024-04566-9. BMC Pediatr. 2024. PMID: 38302912 Free PMC article. Review.
Cited by
-
Evaluation of Bronchiolitis in the Pediatric Population in the United States of America and Canada: A Ten-Year Review.Cureus. 2023 Aug 12;15(8):e43393. doi: 10.7759/cureus.43393. eCollection 2023 Aug. Cureus. 2023. PMID: 37706121 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical